Literature DB >> 15770239

Positron emission tomography of regional brain metabolic responses to a serotonergic challenge in major depressive disorder with and without borderline personality disorder.

Maria A Oquendo1, Aleksandra Krunic, Ramin V Parsey, Matthew Milak, Kevin M Malone, Amy Anderson, Ronald L van Heertum, J John Mann.   

Abstract

Previous neuroimaging studies of major depression have not controlled for the presence of personality disorders characterized by impulsive aggressive behavior, such as borderline personality disorder (BPD). Using positron emission tomography (PET), we studied regional glucose uptake in response to fenfluramine (FEN) in depressed subjects with BPD (n=11) and depressed patients without Cluster B Axis II disorders (n=8). Subjects were scanned while medication-free after a single blind placebo administration and after FEN on a second day. Brain responses were measured by PET imaging of [18F]fluorodeoxyglucose (FDG) and serial prolactin levels. Scans were compared at a voxel level using statistical parametric mapping. Correlations of changes in relative regional cerebral uptake (rCMRglu) with clinical measures were assessed. Depressed borderline patients had greater relative activity in parietotemporal cortical regions (BA 40, BA 22, and BA 42) before and after FEN activation compared to those without BPD. They also had less relative uptake in the anterior cingulate cortex (BA 32) at baseline compared to depressed patients without BPD and FEN abolished this difference. Impulsivity was positively correlated with rCMRglu in superior and middle frontal cortex (BA 6 and 44). Hostility was positively correlated with rCMRglu in temporal cortical regions (BA 21 and 22). In conclusions, borderline pathology in the context of a Major Depressive Disorder is associated with altered activity in parietotemporal and anterior cingulate cortical regions. Controlling for the presence of BPD in future imaging studies of mood disorders may elucidate similarities and differences in regional serotonergic function in these two often comorbid disorders.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15770239     DOI: 10.1038/sj.npp.1300689

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  13 in total

1.  Fronto-limbic dysfunction in response to facial emotion in borderline personality disorder: an event-related fMRI study.

Authors:  Michael J Minzenberg; Jin Fan; Antonia S New; Cheuk Y Tang; Larry J Siever
Journal:  Psychiatry Res       Date:  2007-07-02       Impact factor: 3.222

2.  Positron emission tomography study of regional brain metabolic responses to a serotonergic challenge in major depressive disorder with and without comorbid lifetime alcohol dependence.

Authors:  Leo Sher; Matthew S Milak; Ramin V Parsey; Juan J Carballo; Thomas B Cooper; Kevin M Malone; Maria A Oquendo; J John Mann
Journal:  Eur Neuropsychopharmacol       Date:  2007-05-02       Impact factor: 4.600

3.  Neuron density and serotonin receptor binding in prefrontal cortex in suicide.

Authors:  Mark D Underwood; Suham A Kassir; Mihran J Bakalian; Hanga Galfalvy; J John Mann; Victoria Arango
Journal:  Int J Neuropsychopharmacol       Date:  2011-05-09       Impact factor: 5.176

4.  Increased anterior cingulate cortex and hippocampus activation in Complex PTSD during encoding of negative words.

Authors:  Kathleen Thomaes; Ethy Dorrepaal; Nel Draijer; Michiel B de Ruiter; Bernet M Elzinga; Zsuzsika Sjoerds; Anton J van Balkom; Johannes H Smit; Dick J Veltman
Journal:  Soc Cogn Affect Neurosci       Date:  2011-12-07       Impact factor: 3.436

Review 5.  Borderline personality disorder: considerations for inclusion in the Massachusetts parity list of "biologically-based" disorders.

Authors:  Mary Ellen Foti; Jeffrey Geller; Laura S Guy; John G Gunderson; Brian A Palmer; Lisa M Smith
Journal:  Psychiatr Q       Date:  2011-06

Review 6.  Borderline personality disorder and depression: an update.

Authors:  Maria Luca; Antonina Luca; Carmela Calandra
Journal:  Psychiatr Q       Date:  2012-09

7.  Pretreatment regional brain glucose uptake in the midbrain on PET may predict remission from a major depressive episode after three months of treatment.

Authors:  Matthew S Milak; Ramin V Parsey; Leilani Lee; Maria A Oquendo; Doreen M Olvet; Francoise Eipper; Kevin Malone; J John Mann
Journal:  Psychiatry Res       Date:  2009-05-14       Impact factor: 3.222

8.  Experiences of traumatic events and associations with PTSD and depression development in urban health care-seeking women.

Authors:  Jessica M Gill; Gayle G Page; Phyllis Sharps; Jacquelyn C Campbell
Journal:  J Urban Health       Date:  2008-06-25       Impact factor: 3.671

9.  Serotonergic responses in depressed patients with or without a history of alcohol use disorders and healthy controls.

Authors:  Leo Sher; Barbara H Stanley; Thomas B Cooper; Kevin M Malone; J John Mann; Maria A Oquendo
Journal:  Eur Neuropsychopharmacol       Date:  2008-06-30       Impact factor: 4.600

10.  Plasma polyunsaturated fatty acids and regional cerebral glucose metabolism in major depression.

Authors:  M Elizabeth Sublette; Matthew S Milak; Joseph R Hibbeln; Peter J Freed; Maria A Oquendo; Kevin M Malone; Ramin V Parsey; J John Mann
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2009-01-06       Impact factor: 4.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.